Polymorphisms in base excision repair genes: Breast cancer risk and individual radiosensitivity

World Journal of Clinical Oncology

Volumn 5, Issue 5, 2014, Pages 874-882

  Patrono, Clarice ^a   Sterpone, Silvia ^b   Testa, Antonella ^a   Cozzi, Renata ^b  

^a ENEA   (Italy)

^b ROMA TRE UNIVERSITY   (Italy)

Author keywords

Base excision repair; Breast cancer; Polymorphisms; Radiosensitivity; Susceptibility

Indexed keywords

EID: 84938387352     PISSN: None     EISSN: 22184333     Source Type: Journal    
DOI: 10.5306/wjco.v5.i5.874     Document Type: Article

References (48)

1. Bray F, Ren JS, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer 2013; 132: 1133-1145 [PMID: 22752881 DOI: 10.1002/ijc.27711]
2. Bogdanova N, Helbig S, Dörk T. Hereditary breast cancer: ever more pieces to the polygenic puzzle. Hered Cancer Clin Pract 2013; 11: 12 [PMID: 24025454 DOI: 10.1186/1897-4287-11-12]
3. Ghoussaini M, Pharoah PD, Easton DF. Inherited genetic susceptibility to breast cancer: the beginning of the end or the end of the beginning? Am J Pathol 2013; 183: 1038-1051 [PMID: 23973388 DOI: 10.1016/j.ajpath.2013.07.003]
4. Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 2002; 11: 1513-1530 [PMID: 12496039]
5. Karahalil B, Bohr VA, Wilson DM. Impact of DNA polymorphisms in key DNA base excision repair proteins on cancer risk. Hum Exp Toxicol 2012; 31: 981-1005 [PMID: 23023028 DOI: 10.1177/0960327112444476]
6. Bartsch H, Dally H, Popanda O, Risch A, Schmezer P. Genetic risk profiles for cancer susceptibility and therapy response. Recent Results Cancer Res 2007; 174: 19-36 [PMID: 17302182]
7. Andreassen CN, Alsner J, Overgaard M, Overgaard J. Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes. Radiother Oncol 2003; 69: 127-135 [PMID: 14643949]
8. Costa S, Medeiros R, Schmitt F. DNA signalling/repair genetic polymorphisms and breast cancer risk: a review. Applied Cancer Res 2005; 25: 161-180
9. Robertson AB, Klungland A, Rognes T, Leiros I. DNA repair in mammalian cells: Base excision repair: the long and short of it. Cell Mol Life Sci 2009; 66: 981-993 [PMID: 19153658 DOI: 10.1007/s00018-009-8736-z]
10. Vidal AE, Boiteux S, Hickson ID, Radicella JP. XRCC1 coordinates the initial and late stages of DNA abasic site repair through protein-protein interactions. EMBO J 2001; 20: 6530-6539 [PMID: 11707423]
11. Marsin S, Vidal AE, Sossou M, Ménissier-de Murcia J, Le Page F, Boiteux S, de Murcia G, Radicella JP. Role of XRCC1 in the coordination and stimulation of oxidative DNA damage repair initiated by the DNA glycosylase hOGG1. J Biol Chem 2003; 278: 44068-44074 [PMID: 12933815]
12. Mohrenweiser HW, Xi T, Vázquez-Matías J, Jones IM. Identification of 127 amino acid substitution variants in screening 37 DNA repair genes in humans. Cancer Epidemiol Biomarkers Prev 2002; 11: 1054-1064 [PMID: 12376507]
13. Yi L, Xiao-Feng H, Yun-Tao L, Hao L, Ye S, Song-Tao Q. Association between the XRCC1 Arg399Gln polymorphism and risk of cancer: evidence from 297 case-control studies. PLoS One 2013; 8: e78071 [PMID: 24205095 DOI: 10.1371/journal. pone.0078071]
14. Sterpone S, Cozzi R. Influence of XRCC1 Genetic Polymorphisms on Ionizing Radiation-Induced DNA Damage and Repair. J Nucleic Acids 2010; 2010: pii: 780369 [PMID: 20798883 DOI: 10.4061/2010/780369]
15. Shen MR, Jones IM, Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res 1998; 58: 604-608 [PMID: 9485007]
16. Hao B, Wang H, Zhou K, Li Y, Chen X, Zhou G, Zhu Y, Miao X, Tan W, Wei Q, Lin D, He F. Identification of genetic variants in base excision repair pathway and their associations with risk of esophageal squamous cell carcinoma. Cancer Res 2004; 64: 4378-4384 [PMID: 15205355]
17. Huang Y, Li L, Yu L. XRCC1 Arg399Gln, Arg194Trp and Arg280His polymorphisms in breast cancer risk: a metaanalysis. Mutagenesis 2009; 24: 331-339 [PMID: 19465687 DOI: 10.1093/mutage/gep013]
18. Li H, Ha TC, Tai BC. XRCC1 gene polymorphisms and breast cancer risk in different populations: a meta-analysis. Breast 2009; 18: 183-191 [PMID: 19446452 DOI: 10.1016/j. breast.2009.03.008]
19. Wu K, Su D, Lin K, Luo J, Au WW. XRCC1 Arg399Gln gene polymorphism and breast cancer risk: a meta-analysis based on case-control studies. Asian Pac J Cancer Prev 2011; 12: 2237-2243 [PMID: 22296363]
20. Saadat M, Ansari-Lari M. Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literatures. Breast Cancer Res Treat 2009; 115: 137-144 [PMID: 18481169 DOI: 10.1007/s10549-008-0051-0]
21. Saadat M. Haplotype analysis of XRCC1 (at codons 194 and 399) and susceptibility to breast cancer, a meta-analysis of the literatures. Breast Cancer Res Treat 2010; 124: 785-791 [PMID: 20411322 DOI: 10.1007/s10549-010-0895-y]
22. Brem R, Cox DG, Chapot B, Moullan N, Romestaing P, Gérard JP, Pisani P, Hall J. The XRCC1 -77T->C variant: haplotypes, breast cancer risk, response to radiotherapy and the cellular response to DNA damage. Carcinogenesis 2006; 27: 2469-2474 [PMID: 16829685]
23. Sterpone S, Mastellone V, Padua L, Novelli F, Patrono C, Cornetta T, Giammarino D, Donato V, Testa A, Cozzi R. Single-nucleotide polymorphisms in BER and HRR genes, XRCC1 haplotypes and breast cancer risk in Caucasian women. J Cancer Res Clin Oncol 2010; 136: 631-636 [PMID: 20140625 DOI: 10.1007/s00432-010-0791-1]
24. Liu L, Yuan P, Liu L, Wu C, Zhang X, Guo H, Zhong R, Xu Y, Wu J, Duan S, Rui R, Wu T, Nie S, Miao X, Lin D. A functional-77T>C polymorphism in XRCC1 is associated with risk of breast cancer. Breast Cancer Res Treat 2011; 125: 479-487 [PMID: 20549339 DOI: 10.1007/s10549-010-0959-z]
25. Shinmura K, Yokota J. The OGG1 gene encodes a repair enzyme for oxidatively damaged DNA and is involved in human carcinogenesis. Antioxid Redox Signal 2001; 3: 597-609 [PMID: 11554447]
26. Kohno T, Shinmura K, Tosaka M, Tani M, Kim SR, Sugimura H, Nohmi T, Kasai H, Yokota J. Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene 1998; 16: 3219-3225 [PMID: 9681819]
27. Yuan W, Xu L, Feng Y, Yang Y, Chen W, Wang J, Pang D, Li D. The hOGG1 Ser326Cys polymorphism and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 2010; 122: 835-842 [PMID: 20058067 DOI: 10.1007/s10549-009-0722-5]
28. Ding DP, Zhang Y, He XF. Lack of association between hOGG1 Ser326Cys polymorphism and breast cancer susceptibility in European population. Breast Cancer Res Treat 2011; 129: 1023-1026 [PMID: 21614567 DOI: 10.1007/s10549-011-15 71-6]
29. Gu D, Wang M, Zhang Z, Chen J. Lack of association between the hOGG1 Ser326Cys polymorphism and breast cancer risk: evidence from 11 case-control studies. Breast Cancer Res Treat 2010; 122: 527-531 [PMID: 20054639 DOI: 10.1007/s10549-009-0723-4]
30. Roberts MR, Shields PG, Ambrosone CB, Nie J, Marian C, Krishnan SS, Goerlitz DS, Modali R, Seddon M, Lehman T, Amend KL, Trevisan M, Edge SB, Freudenheim JL. Singlenucleotide polymorphisms in DNA repair genes and association with breast cancer risk in the web study. Carcinogenesis 2011; 32: 1223-1230 [PMID: 21622940 DOI: 10.1093/carcin/bgr096]
31. Kim KY, Han W, Noh DY, Kang D, Kwack K. Impact of genetic polymorphisms in base excision repair genes on the risk of breast cancer in a Korean population. Gene 2013; 532: 192-196 [PMID: 24076439 DOI: 10.1016/j.gene.2013.09.069]
32. Xie H, Xia K, Rong H, Chen X. Genetic polymorphism in hOGG1 is associated with triple-negative breast cancer risk in Chinese Han women. Breast 2013; 22: 707-712 [PMID: 23369609 DOI: 10.1016/j.breast.2012.12.016]
33. Wei B, Zhou Y, Xu Z, Xi B, Cheng H, Ruan J, Zhu M, Hu Q, Wang Q, Wang Z, Yan Z, Jin K, Zhou D, Xuan F, Huang X, Shao J, Lu P. The effect of hOGG1 Ser326Cys polymorphism on cancer risk: evidence from a meta-analysis. PLoS One 2011; 6: e27545 [PMID: 22114677 DOI: 10.1371/journal. pone.0027545]
34. Wood RD, Mitchell M, Sgouros J, Lindahl T. Human DNA repair genes. Science 2001; 291: 1284-1289 [PMID: 11181991]
35. Wu B, Liu HL, Zhang S, Dong XR, Wu G. Lack of an association between two BER gene polymorphisms and breast cancer risk: a meta-analysis. PLoS One 2012; 7: e50857 [PMID: 23272074 DOI: 10.1371/journal.pone.0050857]
36. Kang H, Dai Z, Ma X, Ma L, Jin Y, Liu X, Wang X. A genetic variant in the promoter of APE1 gene (-656 T>G) is associated with breast cancer risk and progression in a Chinese population. Gene 2013; 531: 97-100 [PMID: 23994194 DOI: 10.1016/j.gene.2013.08.052]
37. Parliament MB, Murray D. Single nucleotide polymorphisms of DNA repair genes as predictors of radioresponse. Semin Radiat Oncol 2010; 20: 232-240 [PMID: 20832015 DOI: 10.1016/j.semradonc.2010.05.003]
38. Xie XX, Ouyang SY, Jin HK, Wang H, Zhou JM, Hu BQ. Predictive value of Xrcc1 gene polymorphisms for side effects in patients undergoing whole breast radiotherapy: a metaanalysis. Asian Pac J Cancer Prev 2012; 13: 6121-6128 [PMID: 23464416]
39. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31: 1341-1346 [PMID: 7713792]
40. Pavy JJ, Denekamp J, Letschert J, Littbrand B, Mornex F, Bernier J, Gonzales-Gonzales D, Horiot JC, Bolla M, Bartelink H. EORTC Late Effects Working Group. Late effects toxicity scoring: the SOMA scale. Radiother Oncol 1995; 35: 11-15 [PMID: 7569011]
41. Chang-Claude J, Popanda O, Tan XL, Kropp S, Helmbold I, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Schmezer P, Ambrosone CB. Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients. Clin Cancer Res 2005; 11: 4802-4809 [PMID: 16000577]
42. Giotopoulos G, Symonds RP, Foweraker K, Griffin M, Peat I, Osman A, Plumb M. The late radiotherapy normal tissue injury phenotypes of telangiectasia, fibrosis and atrophy in breast cancer patients have distinct genotype-dependent causes. Br J Cancer 2007; 96: 1001-1007 [PMID: 17325707]
43. Chang-Claude J, Ambrosone CB, Lilla C, Kropp S, Helmbold I, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Schmezer P, Popanda O. Genetic polymorphisms in DNA repair and damage response genes and late normal tissue complications of radiotherapy for breast cancer. Br J Cancer 2009; 100: 1680-1686 [PMID: 19367277 DOI: 10.1038/sj.bjc.6605036]
44. Kerns SL, Stock R, Stone N, Buckstein M, Shao Y, Campbell C, Rath L, De Ruysscher D, Lammering G, Hixson R, Cesaretti J, Terk M, Ostrer H, Rosenstein BS. A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of erectile dysfunction following radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys 2013; 85: e21-e28 [PMID: 23021708 DOI: 10.1016/j.ijrobp.2012.08.003]
45. Barnett GC, Coles CE, Elliott RM, Baynes C, Luccarini C, Conroy D, Wilkinson JS, Tyrer J, Misra V, Platte R, Gulliford SL, Sydes MR, Hall E, Bentzen SM, Dearnaley DP, Burnet NG, Pharoah PD, Dunning AM, West CM. Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study. Lancet Oncol 2012; 13: 65-77 [PMID: 22169268 DOI: 10.1016/S1470-2045(11)70302-3]
46. Andreassen CN, Dikomey E, Parliament M, West CM. Will SNPs be useful predictors of normal tissue radiosensitivity in the future? Radiother Oncol 2012; 105: 283-288 [PMID: 23245645 DOI: 10.1016/j.radonc.2012.11.003]
47. Sapkota Y, Mackey JR, Lai R, Franco-Villalobos C, Lupichuk S, Robson PJ, Kopciuk K, Cass CE, Yasui Y, Damaraju S. Assessing SNP-SNP interactions among DNA repair, modification and metabolism related pathway genes in breast cancer susceptibility. PLoS One 2013; 8: e64896 [PMID: 23755158 DOI: 10.1371/journal.pone.0064896]
48. Smith TR, Levine EA, Freimanis RI, Akman SA, Allen GO, Hoang KN, Liu-Mares W, Hu JJ. Polygenic model of DNA repair genetic polymorphisms in human breast cancer risk. Carcinogenesis 2008; 29: 2132-2138 [PMID: 18701435 DOI: 10.1093/carcin/bgn193]